Evidence map›Paper›PMID 31632852›Full record

ArticlePeerJ2019

A prognostic nomogram for overall survival in male breast cancer with histology of infiltrating duct carcinoma after surgery.

Xin Chai, Mei-Yang Sun, Hong-Yao Jia, Min Wang, Ling Cao, Zhi-Wen Li, Dun-Wei Wang

Abstract read
In one paragraph

Article in PeerJ, 2019. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 7 papers.

0numbers the graph read from it
0cells of the map it votes in
7citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

7 citing papers in PubMed.

  1. Article
  2. Article
  3. Article
  4. Article
  5. Article
  6. Article
  7. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

7 authors.

Xin ChaiBreast Surgery Department, Jilin Provincial Cancer Hospital, Changchun, Jilin, China.
Mei-Yang SunBreast Surgery Department, Jilin Provincial Cancer Hospital, Changchun, Jilin, China.
Hong-Yao JiaBreast Surgery Department, First Hospital of Jilin University, Changchun, Jilin, China.
Min WangDepartment of Pathology, Jilin Provincial Cancer Hospital, Changchun, Jilin, China.
Ling CaoDepartment of Radiation Oncology, Cancer Hospital of Jilin Province, Changchun, Jilin, China.
Zhi-Wen LiDepartment of Anesthesiology, First Hospital of Jilin University, Changchun, Jilin, China.
Dun-Wei WangDepartment of Anesthesiology, First Hospital of Jilin University, Changchun, Jilin, China.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

objectiveThe study was designed to construct and validate a nomogram for predicting overall survival (OS) of male breast cancer (MBC) patients with infiltrating duct carcinoma (IDC).

methodsThe cohort was selected from the Surveillance, Epidemiology, and End Results (SEER) database between January 1, 2004 and December 31, 2013. Univariate and multivariate Cox proportional hazard (PH) regression models were performed. A nomogram was developed based on the significant prognostic indicators of OS. The discriminatory and predictive capacities of nomogram were assessed by Harrell's concordance index (C-index), calibration plots, area under the curve (AUC) and the decision curve analysis (DCA).

resultsThe median and maximal survival time of 1862 eligible patients were 49 and 131 months, respectively. Multivariate analysis showed that age (

conclusionsThe nomogram was able to more accurately predict 3-and 5-year OS of MBC patients with IDC histology than were existing models.

Indexed as

Male breast cancerNomogramOverall survivalPrognosisSEER database

Identifiers

PMID31632852
PMCPMC6796958

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.